---
title: "12 Health Care Stocks Moving In Monday's Intraday Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293241246.md"
description: "During Monday's intraday session, several healthcare stocks experienced significant volatility. Gainers included Zhengye Biotechnology (up 322.6%), Advanced Biomed (up 51.88%), and Axe Compute (up 26.83%). Conversely, major losers featured Karyopharm Therapeutics (down 28.9%), Pomdoctor (down 27.89%), and Dare Bioscience (down 27.05%). The report highlights these price movements alongside respective market capitalizations for the listed companies."
datetime: "2026-07-20T17:05:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293241246.md)
  - [en](https://longbridge.com/en/news/293241246.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293241246.md)
generator: "portal-rs"
---

# 12 Health Care Stocks Moving In Monday's Intraday Session

### Gainers

-   **Zhengye Biotechnology** (NASDAQ:ZYBT) shares increased by 322.6% to $2.95 during Monday's regular session. The company's market cap stands at $33.0 million.
-   **Advanced Biomed** (NASDAQ:ADVB) stock moved upwards by 51.88% to $7.64. The market value of their outstanding shares is at $8.2 million.
-   **Axe Compute** (NASDAQ:AGPU) stock moved upwards by 26.83% to $8.71. The market value of their outstanding shares is at $78.2 million.
-   **Neuronetics** (NASDAQ:STIM) stock increased by 25.3% to $2.03. The company's market cap stands at $112.7 million.
-   **Exicure** (NASDAQ:XCUR) stock rose 17.62% to $1.98. The market value of their outstanding shares is at $10.7 million.
-   **Barinthus Biotherapeutics** (NASDAQ:BRNS) stock increased by 13.6% to $0.63. The market value of their outstanding shares is at $22.6 million.

### Losers

-   **Karyopharm Therapeutics** (NASDAQ:KPTI) shares declined by 28.9% to $6.76 during Monday's regular session. The market value of their outstanding shares is at $215.5 million.
-   **Pomdoctor** (NASDAQ:POM) stock declined by 27.89% to $0.81. The company's market cap stands at $134.6 million.
-   **Dare Bioscience** (NASDAQ:DARE) shares declined by 27.05% to $1.43. The company's market cap stands at $29.3 million.
-   **BioVie** (NASDAQ:BIVI) shares decreased by 19.46% to $1.45. The company's market cap stands at $13.5 million.
-   **Valion Bio** (NASDAQ:VBIO) stock fell 17.76% to $0.42. The company's market cap stands at $1.6 million.
-   **GlucoTrack** (NASDAQ:GCTK) stock fell 17.56% to $0.41. The company's market cap stands at $3.2 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [POM.US](https://longbridge.com/en/quote/POM.US.md)
- [DARE.US](https://longbridge.com/en/quote/DARE.US.md)
- [ZYBT.US](https://longbridge.com/en/quote/ZYBT.US.md)
- [AGPU.US](https://longbridge.com/en/quote/AGPU.US.md)
- [KPTI.US](https://longbridge.com/en/quote/KPTI.US.md)
- [ADVB.US](https://longbridge.com/en/quote/ADVB.US.md)
- [STIM.US](https://longbridge.com/en/quote/STIM.US.md)
- [XCUR.US](https://longbridge.com/en/quote/XCUR.US.md)
- [BRNS.US](https://longbridge.com/en/quote/BRNS.US.md)
- [BIVI.US](https://longbridge.com/en/quote/BIVI.US.md)
- [VBIO.US](https://longbridge.com/en/quote/VBIO.US.md)
- [GCTK.US](https://longbridge.com/en/quote/GCTK.US.md)
- [BIVIW.US](https://longbridge.com/en/quote/BIVIW.US.md)

## Related News & Research

- [Karyopharm grants 1,850 inducement RSUs to two new hires](https://longbridge.com/en/news/297692005.md)
- [Karyopharm seeks FDA accelerated approval for Xpovio-ruxolitinib combo in myelofibrosis](https://longbridge.com/en/news/297509616.md)
- [18:26 ETINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Karyopharm Therapeutics Inc. - KPTI](https://longbridge.com/en/news/297238541.md)
- [Pomdoctor Launches U.S. Expansion Preparations With AI-Driven Healthcare Strategy](https://longbridge.com/en/news/297189060.md)
- [Pomdoctor launches preparations for U.S. market entry](https://longbridge.com/en/news/297181827.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**